StemSation International is providing updates on recent business activities and new business ventures

Plantation, Florida, August 3, 2023 – StemSation International (OTC PINK: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is providing updates on recent company activities as well as corporate planning for the upcoming months.

“Last year we announced the divesting of the Network Marketing business as well as the resignation of our former CEO,” stated Benjamin Silber, CEO of StemSation International. “That allowed us to reduce our debts by over $328,000 as well as reduce payments towards operations of over $50,000 per month,” he continued. “Additionally, we announced the retirement of $264,000 in noteholder debt with the settlement of a lawsuit in June. Since that time, we have focused on further debt restructuring as well as research and development of our licensed technologies for the production and distribution of flavored, canned oxygen products. We are excited to move this business forward as we seek other licensing opportunities and asset acquisitions,” he concluded.

StemSation expects to have additional updates shortly as they fulfill on their current business plan.


StemSation International

Benjamin Silber

About StemSation International

StemSation International, Inc. (OTC PINK: STSN) is researching the developing, marketing and distribution of flavored, canned oxygen products. These products will be distributed in a lifestyle model to the beverage industry as well as colleges, restaurants and bars. StemSation is headquartered in Plantation, Florida.

SEC Disclaimer

This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” Actual results could differ materially from those projected in StemSation international’s (“the Company”) business plan. The corporate updates should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company’s filings may be accessed at the OTC Market’s disclosures at Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.